Fools were out and about this week in an investing world jam-packed with actions and ideas. Here are three articles you might find useful as you decide how to invest your money.
This Drugmaker Stands on a Platform Above the Rest
Here's a suggestion for those who'd like to invest in the pharmaceuticals industry while avoiding the risks associated with getting specific drugs through the FDA approval process and onto the market. ImmunoGen
Fool contributor Brian Orelli reported this week that Novartis
"It's pretty clear that targeted antibodies are the wave of the future," Brian wrote. "Big drugmakers are going to turn their antibody drug candidates into potent killing machines, but it'll be the technology developers like ImmunoGen and Seattle Genetics that will be raking in the dough."
Is Boeing the Perfect Stock?
Before you set out in search of the "perfect stock," you need to know what you're looking for. Fool editor and writer Dan Caplinger offers assistance in a recurring feature that lays out "some of the most basic yet important things to look for in a stock" and then reviews how well one stock measures up.
Boeing
The Top 5 Ways to Lose Money Investing
Fool editor and writer Dan Dzombak gave investors five tips for building a strong portfolio. Tip No. 1 is to avoid putting money into businesses or investment instruments if you can't understand how they work.
Dan gives two examples of simple businesses that anyone can understand: DVD provider Netflix